Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line<i>AIP</i>Mutations and Pituitary Adenomas: An International Collaborative Study
Adrian Daly(Centre Hospitalier Universitaire de Liège), Anne‐Paule Gimenez‐Roqueplo(Délégation Paris 5), Ralf Paschke(University of Calgary), Auli Karhu(University of Helsinki), Elisa Verrua(Inserm), Luciana Ansaneli Naves(Universidade de Brasília), Robert J. Weil(Cleveland Clinic), Anne Barlier(Inserm), Wouter W. de Herder(Erasmus University Rotterdam), Sebastian Neggers(Erasmus MC), Ernesto De Menis(Inserm), Cristina L. Ronchi(University of Birmingham), Dominique Maiter(Cliniques Universitaires Saint-Luc), Rodrigo A. Toledo(Instituto de Salud Carlos III), Patrick Pétrossians(Centre Hospitalier Universitaire de Liège), Juliet Jennings(Royal Children's Hospital), Roberto Salvatori(Johns Hopkins University), Gérald Raverot(Université Claude Bernard Lyon 1), Marc Popelier(Sorbonne Université), Chiara Villa(Centre National de la Recherche Scientifique), Mirtha Guitelman(University of Helsinki), Antoine Tabarin(Université de Bordeaux), Gustavo Barcelos Barra(Sabin Medicina Diagnostica (Brazil)), Jean-François Vanbellinghen(University of Liège), Philippe Émy(Inserm), Renato Cozzi(Ospedale Maggiore), Maria Yaneva(Medical University of Sofia), Antti Raappana(Oulu University Hospital), Carola Saloranta(Lund University), Flavia Magri(University of Pavia), Tapani Ebeling(Inserm), Pasi Salmela(Oulu University Hospital), Marie‐Lise Jaffrain‐Rea(Inserm), Matti Välimäki(University of Helsinki), Laure Cazabat(Hôpital Foch), Elina Heliövaara, Marianthi Georgitsi(University of Helsinki), María A. Tichomirowa(University of Liège), Timo Sane(Helsinki University Hospital), Arnaud Murat(Centre National de la Recherche Scientifique), Vinciane Corman(Centre hospitalier régional de la Citadelle), José Ignacio Labarta Aizpún(Hospital Universitario Miguel Servet), Marie-Thérèse Hagelstein(University of Liège), Eija Eloranta(Oulu University Hospital), Maria Stefania Lagonigro(University of Pavia), Georges Halaby(Hôtel-Dieu de France), Maria Sabaté(Austral University), Outi Vierimaa(Oulu University Hospital), A Ferrández Longás(Hospital Universitario Miguel Servet)
Cited by 374
Related Papers
Gastroenteropancreatic neuroendocrine tumours
|The Lancet Oncology|2008|1.8k
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
|European Journal of Endocrinology|2016|1.5k
Treatment With the Radiolabeled Somatostatin Analog [ <sup>177</sup> Lu-DOTA <sup>0</sup> ,Tyr <sup>3</sup> ]Octreotate: Toxicity, Efficacy, and Survival
|Journal of Clinical Oncology|2008|1.4k
Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases
|Journal of Clinical Oncology|2011|1.4k
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
|New England Journal of Medicine|2012|863